Strata Critical Medical, Inc. (SRTA) vs YD Bio Limited Ordinary Shares (YDES)

A side-by-side comparison of Strata Critical Medical, Inc. and YD Bio Limited Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — SRTA vs YDES

growth of $100 · dividends reinvested · last 1y
SRTA +8.6% (+8.6%/yr)YDES -40.9% (-40.9%/yr)SRTA compounded faster over this window
50100150200Start $1002026$109$59
SRTA YDES

SRTA vs YDES: by the numbers

  • •YDES is the larger company ($436M vs $411M market cap).
  • •SRTA is profitable (15.71% net margin) while YDES runs a net loss (-1392.61%).

Metrics side by side

Valuation

MetricSRTAYDES
P/E ratio9.54N/A
P/S ratio1.61N/A
P/B ratio1.47N/A

Profitability

MetricSRTAYDES
Gross margin20.56%-7.06%
Operating margin-7.97%-883.31%
Net margin15.71%-1392.61%
ROE14.40%-66.49%
ROIC-7.11%N/A

Growth (annualized)

MetricSRTAYDES
Revenue CAGR (5Y)46.05%N/A
Total return CAGR (5Y)-13.77%N/A

Frequently asked

Is SRTA or YDES more profitable?
SRTA runs the higher net margin — SRTA at 15.71% versus YDES at -1392.61%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.